Protagonist Therapeutics, Inc. (PTGX)

104.49 -1.40 (-1.32%) USD  |  NASDAQ  |  Apr 22, 11:50
More

Protagonist Therapeutics Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Johnson & Johnson Upgrade
AbbVie, Inc. Upgrade
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade